XOMA Corp Business Finance Contracts & Agreements

106 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 1, dated June 3, 2024, to the Royalty Purchase Agreement, dated as of June 21, 2023, by and between XOMA (US) LLC and LadRx Corporation
Purchase Agreements
XOMA Corp
Biotechnology
2025
Amendment No. 1, dated March 4, 2024, to the Royalty Purchase Agreement dated March 22, 2021 between XOMA (US) LLC and Viracta Therapeutics, Inc
Purchase Agreements
XOMA Corp
Biotechnology
2025
Letter Agreement dated August 26, 2021 between Presidio Trust and Kinnate Biopharma Inc
Trust Agreements
XOMA Corp
Biotechnology
DE
2024
Amendment No. 1 to Royalty Purchase Agreement entered into as of March 4, 2024 by and between Viracta
Purchase Agreements
XOMA Corp
Biotechnology
2024
Payment Interest Purchase Agreement by and between
Purchase Agreements
XOMA Corp
Biotechnology
DE
2024
Sale, Contribution and Servicing Agreement
Servicing Agreements
XOMA Corp
Biotechnology
DE
2024
Loan Agreement dated December 15, 2023, between XRL 1 LLC, the lenders from time to time party thereto and Blue Owl Capital Corporation
Loan Agreements
XOMA Corp
Biotechnology
DE
2024
Form of Warrant (December 2023) ($50.00 Exercise Price)
Warrant Agreements
XOMA Corp
Biotechnology
NY
2023
Form of Warrant (December 2023) ($42.50 Exercise Price)
Warrant Agreements
XOMA Corp
Biotechnology
NY
2023
Form of Warrant (December 2023) ($35.00 Exercise Price)
Warrant Agreements
XOMA Corp
Biotechnology
NY
2023
Royalty Purchase Agreement, dated as of June 21, 2023, by and between XOMA (US) LLC and LadRx Corporation
Purchase Agreements
XOMA Corp
Biotechnology
DE
2023
Assignment and Assumption Agreement, dated as of June 21, 2023, by and between XOMA (US) LLC and LadRx Corporation
Assignment Agreements
XOMA Corp
Biotechnology
NY
2023
Payment Interest Purchase Agreement, dated March 29, 2023, by and between Aptevo Therapeutics Inc. and XOMA (US) LLC
Purchase Agreements
XOMA Corp
Biotechnology
DE
2023
Amendment and Restatement, dated February 2, 2017, to the Asset Purchase Agreement, dated November 4, 2015, and License Agreement, dated March 23, 2016, between XOMA Corporation...
Purchase Agreements
XOMA Corp
Biotechnology
2022
Commercial Payment Purchase Agreement, dated October 6, 2021, by and among XOMA (US) LLC and Affitech Research AS
Purchase Agreements
XOMA Corp
Biotechnology
CA
2022
Royalty Purchase Agreement, dated July 14, 2021, by and among XOMA (US) LLC and Kuros Royalty Fund (US) LLC
Purchase Agreements
XOMA Corp
Biotechnology
CA
2021
Royalty Purchase Agreement dated March 22, 2021 between XOMA (US) LLC and Viracta Therapeutics, Inc
Purchase Agreements
XOMA Corp
Biotechnology
CA
2021
Deposit Agreement, dated effective as of April 9, 2021, by and among the Company, American Stock Transfer & Trust Company LLC, as depositary, and the holders of the depositary...
Stock Agreements
XOMA Corp
Biotechnology
NY
2021
Underwriting Agreement, dated as of April 6, 2021, by and among the Company and B. Riley Securities, Inc., as representative of the several underwriters named therein
Underwriting Agreements
XOMA Corp
Biotechnology
CA
2021
Amendment No. 1, dated March 10, 2021, to the Common Stock Sales Agreement, dated December 18, 2018, by and between XOMA Corporation and H.C. Wainwright & Co., LLC
Stock Agreements
XOMA Corp
Biotechnology
NY
2021
Underwriting Agreement, dated as of December 10, 2020, by and between the Company and B. Riley Securities, Inc., as representative of the several underwriters named therein
Underwriting Agreements
XOMA Corp
Biotechnology
CA
2020
Amendment No. 3, dated March 31, 2020, to the Common Stock Purchase Agreement, dated December 6, 2017, between XOMA Corporation and Rezolute, Inc. (formerly AntriaBio, Inc.)
Stock Agreements
XOMA Corp
Biotechnology
CA
2020
Investment Agreement, dated November 19, 2019
Investment Agreements
XOMA Corp
Biotechnology
DE
2019
Royalty Purchase Agreement dated September 26, 2019 between XOMA (US) LLC and Palobiofarma, S.L
Purchase Agreements
XOMA Corp
Biotechnology
CA
2019
Royalty Purchase Agreement dated April 7, 2019, between XOMA (US) LLC and Aronora, Inc
Purchase Agreements
XOMA Corp
Biotechnology
CA
2019
First Amendment, dated March 4, 2019, to the Loan and Security Agreement dated May 7, 2018, between XOMA Corporation, XOMA (US) LLC and XOMA Technology, Ltd. and Silicon Valley...
Loan Agreements
XOMA Corp
Biotechnology
2019
Form of Warrant (March 2019 Warrant)
Warrant Agreements
XOMA Corp
Biotechnology
CA
2019
Amendment No. 2, dated January 7, 2019, to the Common Stock Purchase Agreement, dated December 6, 2017, between XOMA (US) LLC and Rezolute, Inc. (formerly AntriaBio)
Stock Agreements
XOMA Corp
Biotechnology
CA
2019
Common Stock Sales Agreement, dated December 18, 2018, by and between XOMA Corporation and H.C. Wainwright & Co., LLC
Stock Agreements
XOMA Corp
Biotechnology
NY
2018
Investment Agreement, dated November 6, 2018
Investment Agreements
XOMA Corp
Biotechnology
DE
2018
Royalty Purchase Agreement dated September 20, 2018, between XOMA Corporation and Agenus Inc
Purchase Agreements
XOMA Corp
Biotechnology
DE
2018
Loan and Security Agreement dated May 7, 2018, between XOMA Corporation, XOMA (US) LLC and XOMA Technology, Ltd. and Silicon Valley Bank
Loan Agreements
XOMA Corp
Biotechnology
CA
2018
Form of Warrant (May 2018 Warrant)
Warrant Agreements
XOMA Corp
Biotechnology
CA
2018
Amendment No.1, dated March 30, 2018 to the Common Stock Purchase Agreement, dated December 6, 2017, between XOMA Corporation and Rezolute, Inc. (formerly AntriaBio, Inc.)
Stock Agreements
XOMA Corp
Biotechnology
2018
Common Stock Purchase Agreement, dated December 6, 2017, between XOMA (US) LLC and Rezolute, Inc. (formerly AntriaBio)
Stock Agreements
XOMA Corp
Biotechnology
CA
2018
Amendment No. 3, effective January 17, 2017, to the Loan Agreement, effective December 30, 2010, by and among XOMA (US) LLC, Les Laboratoires Servier and Institut de Recherches...
Loan Agreements
XOMA Corp
Biotechnology
2018
Amendment No. 1, dated December 20, 2016, to Loan and Security Agreement, dated February 27, 2015, by and among XOMA Corporation, XOMA(US) LLC and XOMA Commercial as borrowers and...
Loan Agreements
XOMA Corp
Biotechnology
2018
Amendment to Secured Note Agreement, executed September 22, 2017, by and between Novartis Vaccines and Diagnostics, Inc. (formerly Chiron Corporation) and XOMA (US) LLC
Note Agreements
XOMA Corp
Biotechnology
2018
Common Stock Purchase Agreement, dated August 24, 2017, by and between XOMA Corporation and Novartis Pharma AG
Stock Agreements
XOMA Corp
Biotechnology
NY
2017
XOMA CORPORATION AMENDED 2015 EMPLOYEE STOCK PURCHASE PLAN (as amended through May 18, 2017)
Stock Agreements
XOMA Corp
Biotechnology
DE
2017